J SchmitzA OwyangE OldhamIL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokinesImmunity23479490200510.1016/j.immuni.2005.09.01516286016

ES BaekkevoldM RoussigneT YamanakaMolecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venulesAm J Pathol1636979200310.1016/S0002-9440(10)63631-012819012

V CarriereL RousselN OrtegaIL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivoProc Natl Acad Sci USA104282287200710.1073/pnas.060685410417185418

CA HudsonGP ChristophiRC GruberJR WilmoreDA LawrencePT MassaInduction of IL-33 expression and activity in central nervous system gliaJ Leukoc Biol84631643200810.1189/jlb.120783018552204

AM KuchlerJ PollheimerJ BaloghNuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activationAm J Pathol17312291242200810.2353/ajpath.2008.08001418787100

M IikuraH SutoN KajiwaraIL-33 can promote survival, adhesion and cytokine production in human mast cellsLab Invest87971978200710.1038/labinvest.370066317700564

D MoulinO DonzeD Talabot-AyerF MezinG PalmerC GabayInterleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cellsCytokine40216225200710.1016/j.cyto.2007.09.01318023358

R KakkarRT LeeThe IL-33/ST2 pathway: therapeutic target and novel biomarkerNat Rev Drug Discov7827840200810.1038/nrd266018827826

C CayrolJP GirardThe IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1Proc Natl Acad Sci USA10690219026200910.1073/pnas.081269010619439663

C MoussionN OrtegaJP GirardThe IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’?PLoS One3e3331200818836528

BP LeungD XuS CulshawIB McInnesFY LiewA novel therapy of murine collagen-induced arthritis with soluble T1/ST2J Immunol173145150200410.4049/jimmunol.173.1.14515210768

D XuHR JiangP KewinIL-33 exacerbates antigen-induced arthritis by activating mast cellsProc Natl Acad Sci USA1051091310918200810.1073/pnas.080189810518667700

G PalmerD Talabot-AyerC LamacchiaInhibition of interleukin-33 signaling attenuates the severity of experimental arthritisArthritis Rheum60738749200910.1002/art.2430519248109

WA Verri JrFO SoutoSM VieiraIL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapyAnn Rheum Dis6916971703201010.1136/ard.2009.12265520472598

Y MatsuyamaH OkazakiH TamemotoIncreased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritisJ Rheumatol371825201010.3899/jrheum.09049219918048

S KaiedaK ShinPA NigrovicSynovial fibroblasts promote the expression and granule accumulation of tryptase via interleukin-33 and its receptor ST-2 (IL1RL1)J Biol Chem2852147821486201010.1074/jbc.M110.11499120427273

G PalmerS TrollietD Talabot-AyerF MezinD MagneC GabayPre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1)Cytokine31153160200510.1016/j.cyto.2005.03.007

S SharmaN KulkMF NoldThe IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokinesJ Immunol18054775482200810.4049/jimmunol.180.8.547718390730

FC ArnettSM EdworthyDA BlochThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum31315324198810.1002/art.17803103023358796

T ZimmermannE KunischR PfeifferIsolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture - primary culture cells markedly differ from fourth-passage cellsArthritis Res37276200110.1186/ar142

A HirthA SkapenkoRW KinneF EmmrichH Schulze-KoopsU SackCytokine mRNA and protein expression in primary-culture and repeated-passage synovial fibroblasts from patients with rheumatoid arthritisArthritis Res4117125200210.1186/ar39111879547

N SwaroopF ChenL WangS DokkaD ToledoY RojanasakulInhibition of nuclear transcription factor-kappaB by specific IkappaB kinase peptide inhibitorPharm Res1816311633200110.1023/A:101305101909811758774

DB GlassHC ChengL Mende-MuellerJ ReedDA WalshPrimary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor proteinJ Biol Chem264880288101989

S AlsalamehRJ AminE KunischHE JasinRW KinnePreferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55J Rheumatol30168016902003

E KunischM GandesiriR FuhrmannA RothR WinterRW KinnePredominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritisAnn Rheum Dis6610431051200710.1136/ard.2006.062521

D PohlersA BeyerD KoczanT WilhelmHJ ThiesenRW KinneConstitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblastsArthritis Res Ther9R59200710.1186/ar221717594488

D PretzelD PohlersS WeinertRW KinneIn vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilageArthritis Res Ther11R25200910.1186/ar261819226472

LM CarruthS DemczukSB MizelInvolvement of a calpain-like protease in the processing of the murine interleukin 1 alpha precursorJ Biol Chem266121621216719912061304

WM SidersJC KlimovitzSB MizelCharacterization of the structural requirements and cell type specificity of IL-1 alpha and IL-1 beta secretionJ Biol Chem268221702217419938408078

FM BrennanIB McInnesEvidence that cytokines play a role in rheumatoid arthritisJ Clin Invest11835373545200810.1172/JCI3638918982160

B GrimbacherWK AicherHH PeterH EibelTNF-alpha induces the transcription factor Egr-1, pro-inflammatory cytokines and cell proliferation in human skin fibroblasts and synovial lining cellsRheumatol Int17185192199810.1007/s0029600500329542779

H KitasatoM NodaT AkahoshiActivated Ras modifies the proliferative response of rheumatoid synovial cells to TNF-alpha and TGF-alphaInflamm Res50592597200110.1007/PL0000023911822784

K AupperleB BennettZ HanD BoyleA ManningG FiresteinNF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytesJ Immunol16627052711200110.4049/jimmunol.166.4.270511160335

Y TakadaH IchikawaA PataerS SwisherBB AggarwalGenetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activationOncogene2612011212200710.1038/sj.onc.120990616924232

L RousselM ErardC CayrolJP GirardMolecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocketEMBO Rep910061012200810.1038/embor.2008.14518688256

M Funakoshi-TagoK TagoM HayakawaTRAF6 is a critical signal transducer in IL-33 signaling pathwayCell Signal2016791686200810.1016/j.cellsig.2008.05.01318603409

T Pecaric-PetkovicSA DidichenkoS KaempferN SpieglCA DahindenHuman basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33Blood11315261534200910.1182/blood-2008-05-15781818955562

M SuzukawaM IikuraR KoketsuAn IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptorJ Immunol18159815989200810.4049/jimmunol.181.9.598118941187

P BuflerF Gamboni-RobertsonT AzamSH KimCA DinarelloInterleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharideBiochem J381503510200410.1042/BJ2004021715046617